We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLY
6951
DELISTED
Medley Management Inc
MDLY
-11
Closed
CCRC
6952
DELISTED
China Customer Relations Centers, Inc
CCRC
-1
Closed
LINX
6953
DELISTED
Linx S.A.
LINX
$0 ﹤0.01%
4
-47,778
-100% -$378K
HWCC
6954
DELISTED
Houston Wire & Cable Company
HWCC
$0 ﹤0.01%
6
-173
-97% -$710
STND
6955
DELISTED
Standard AVB Financial Corp. Common Stock
STND
-25
Closed -$1K
AEGN
6956
CALL
DELISTED
Aegion Corp
AEGN
-6,500
Closed -$139K
RUHN
6957
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$0 ﹤0.01%
8
-46
-85% -$288
VAR
6958
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
-100
Closed -$12K
SYNC
6959
DELISTED
Synacor, Inc.
SYNC
$0 ﹤0.01%
+1
New +$2
FBSS
6960
DELISTED
Fauquier Bankshares Inc
FBSS
-32
Closed -$1K
OTEL
6961
DELISTED
Otelco, Inc. Class A
OTEL
-17
Closed
UROV
6962
DELISTED
Urovant Sciences Ltd.
UROV
-149
Closed -$1K
NEOS
6963
DELISTED
Neos Therapeutics, Inc
NEOS
$0 ﹤0.01%
78
-43
-36% -$65
OXFD
6964
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-13,875
Closed -$231K
CZZ
6965
PUT
DELISTED
Cosan Limited
CZZ
-500,000
Closed -$7.45M
TALO.WS
6966
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$0 ﹤0.01%
94
CBMG
6967
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$0 ﹤0.01%
6
-5,961
-100% -$99.4K
CEL
6968
DELISTED
Cellcom Israel, Ltd.
CEL
-3,439
Closed -$10K
OSB
6969
DELISTED
Norbord Inc.
OSB
-1,440
Closed -$34K
TCCO
6970
DELISTED
Technical Communications Corporation
TCCO
-2
Closed
PRCP
6971
DELISTED
Perceptron Inc
PRCP
-70
Closed
RELV
6972
DELISTED
Reliv International Inc
RELV
-7
Closed
NTRP
6973
PUT
DELISTED
Neurotrope, Inc. Common
NTRP
-52,300
Closed -$42K
TRQ
6974
DELISTED
Turquoise Hill Resources Ltd
TRQ
$0 ﹤0.01%
30
-592
-95% -$3.04K
ZOM
6975
DELISTED
Zomedica Corp.
ZOM
$0 ﹤0.01%
+1
New

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.